Module 5: Regulatory Compliance & Prescribing
1. SUSMP Cannabinoid Scheduling
2. Compounding & Prescribing Boundaries
• Schedule 4 (Prescription Only): CBD ≥98% total cannabinoid content
• Schedule 8 (Controlled): THC, derivatives, or CBD <98% purity
• Concentration Limits: Strict adherence to registered standards
• Cascading Rule: APVMA products prioritized over compounding
3. Mandatory Record-Keeping
4. Product Communications
• 7-Year Retention: Mandatory preservation of medical audit logs
• Controlled Register: Real-time tracking of stock & destruction
• Advertising Restrictions: Zero public promotion of S4/S8 items
• Informed Consent: Written consent for unapproved product use